A Janoshik COA that verifies via unique key on the laboratory's official site is strong evidence that the peptide is what it claims to be
The conjugate research and much of the mechanistic work described here remains preclinical, conducted in animal models and cell systems rather than in human clinical trials
Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)
The company announced that ongoing use of semaglutide (Wegovy) led to a 57% greater reduction in the risk of heart attack, stroke, or death in people with obesity or cardiovascular disease compared with tirzepatide users
Anti-inflammatory Treatment for Major Depressive Disorder: Implications for Patients with an Elevated Immune Profile and Non-responders to Standard Antidepressant Therapy